nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—Alkylating Activity—Mechlorethamine—lymphatic system cancer	0.528	0.591	CiPCiCtD
Busulfan—Alkylating Activity—Carmustine—lymphatic system cancer	0.366	0.409	CiPCiCtD
Busulfan—MGST2—Podofilox—Teniposide—lymphatic system cancer	0.00162	0.669	CbGdCrCtD
Busulfan—MGST2—Azacitidine—Fludarabine—lymphatic system cancer	0.000412	0.17	CbGdCrCtD
Busulfan—CYP3A4—Cytarabine—lymphatic system cancer	0.000396	0.318	CbGbCtD
Busulfan—CYP3A4—Teniposide—lymphatic system cancer	0.00039	0.313	CbGbCtD
Busulfan—MGST2—Azacitidine—Cytarabine—lymphatic system cancer	0.000389	0.161	CbGdCrCtD
Busulfan—CYP3A4—Mitoxantrone—lymphatic system cancer	0.000273	0.219	CbGbCtD
Busulfan—CYP3A4—Vincristine—lymphatic system cancer	0.000188	0.151	CbGbCtD
Busulfan—Anaemia—Bleomycin—lymphatic system cancer	8.54e-05	0.000833	CcSEcCtD
Busulfan—Feeling abnormal—Fludarabine—lymphatic system cancer	8.47e-05	0.000827	CcSEcCtD
Busulfan—Asthenia—Teniposide—lymphatic system cancer	8.39e-05	0.000819	CcSEcCtD
Busulfan—Cystitis noninfective—Methotrexate—lymphatic system cancer	8.34e-05	0.000814	CcSEcCtD
Busulfan—Pruritus—Teniposide—lymphatic system cancer	8.28e-05	0.000808	CcSEcCtD
Busulfan—Arrhythmia—Carmustine—lymphatic system cancer	8.27e-05	0.000807	CcSEcCtD
Busulfan—Leukopenia—Bleomycin—lymphatic system cancer	8.27e-05	0.000807	CcSEcCtD
Busulfan—Cystitis—Methotrexate—lymphatic system cancer	8.25e-05	0.000805	CcSEcCtD
Busulfan—Cardiac disorder—Vincristine—lymphatic system cancer	8.2e-05	0.000801	CcSEcCtD
Busulfan—Alopecia—Carmustine—lymphatic system cancer	8.18e-05	0.000799	CcSEcCtD
Busulfan—Skin exfoliation—Methotrexate—lymphatic system cancer	8.15e-05	0.000796	CcSEcCtD
Busulfan—Body temperature increased—Fludarabine—lymphatic system cancer	8.13e-05	0.000793	CcSEcCtD
Busulfan—Mental disorder—Carmustine—lymphatic system cancer	8.11e-05	0.000792	CcSEcCtD
Busulfan—Malnutrition—Carmustine—lymphatic system cancer	8.06e-05	0.000787	CcSEcCtD
Busulfan—Erythema—Carmustine—lymphatic system cancer	8.06e-05	0.000787	CcSEcCtD
Busulfan—Cough—Bleomycin—lymphatic system cancer	8.06e-05	0.000786	CcSEcCtD
Busulfan—Angiopathy—Vincristine—lymphatic system cancer	8.02e-05	0.000783	CcSEcCtD
Busulfan—Aplastic anaemia—Methotrexate—lymphatic system cancer	8.02e-05	0.000783	CcSEcCtD
Busulfan—Diarrhoea—Teniposide—lymphatic system cancer	8e-05	0.000781	CcSEcCtD
Busulfan—Mediastinal disorder—Vincristine—lymphatic system cancer	7.97e-05	0.000777	CcSEcCtD
Busulfan—Myalgia—Bleomycin—lymphatic system cancer	7.86e-05	0.000767	CcSEcCtD
Busulfan—Chest pain—Bleomycin—lymphatic system cancer	7.86e-05	0.000767	CcSEcCtD
Busulfan—Alopecia—Vincristine—lymphatic system cancer	7.81e-05	0.000762	CcSEcCtD
Busulfan—Coma—Methotrexate—lymphatic system cancer	7.8e-05	0.000762	CcSEcCtD
Busulfan—Back pain—Carmustine—lymphatic system cancer	7.8e-05	0.000761	CcSEcCtD
Busulfan—Mental disorder—Vincristine—lymphatic system cancer	7.74e-05	0.000756	CcSEcCtD
Busulfan—Chills—Mitoxantrone—lymphatic system cancer	7.72e-05	0.000754	CcSEcCtD
Busulfan—Neoplasm—Methotrexate—lymphatic system cancer	7.72e-05	0.000754	CcSEcCtD
Busulfan—Bladder pain—Methotrexate—lymphatic system cancer	7.72e-05	0.000754	CcSEcCtD
Busulfan—Arrhythmia—Mitoxantrone—lymphatic system cancer	7.69e-05	0.00075	CcSEcCtD
Busulfan—Gynaecomastia—Methotrexate—lymphatic system cancer	7.64e-05	0.000746	CcSEcCtD
Busulfan—Alopecia—Mitoxantrone—lymphatic system cancer	7.61e-05	0.000742	CcSEcCtD
Busulfan—Pulmonary oedema—Methotrexate—lymphatic system cancer	7.6e-05	0.000742	CcSEcCtD
Busulfan—Confusional state—Bleomycin—lymphatic system cancer	7.6e-05	0.000742	CcSEcCtD
Busulfan—Hypersensitivity—Fludarabine—lymphatic system cancer	7.57e-05	0.000739	CcSEcCtD
Busulfan—Oedema—Bleomycin—lymphatic system cancer	7.54e-05	0.000735	CcSEcCtD
Busulfan—Erythema—Mitoxantrone—lymphatic system cancer	7.49e-05	0.000731	CcSEcCtD
Busulfan—Infection—Bleomycin—lymphatic system cancer	7.49e-05	0.000731	CcSEcCtD
Busulfan—Anaemia—Carmustine—lymphatic system cancer	7.45e-05	0.000727	CcSEcCtD
Busulfan—Back pain—Vincristine—lymphatic system cancer	7.44e-05	0.000726	CcSEcCtD
Busulfan—Vomiting—Teniposide—lymphatic system cancer	7.44e-05	0.000726	CcSEcCtD
Busulfan—Sepsis—Methotrexate—lymphatic system cancer	7.41e-05	0.000723	CcSEcCtD
Busulfan—Agitation—Carmustine—lymphatic system cancer	7.41e-05	0.000723	CcSEcCtD
Busulfan—Thrombocytopenia—Bleomycin—lymphatic system cancer	7.38e-05	0.00072	CcSEcCtD
Busulfan—Asthenia—Fludarabine—lymphatic system cancer	7.38e-05	0.00072	CcSEcCtD
Busulfan—Rash—Teniposide—lymphatic system cancer	7.37e-05	0.00072	CcSEcCtD
Busulfan—Dermatitis—Teniposide—lymphatic system cancer	7.37e-05	0.000719	CcSEcCtD
Busulfan—Headache—Teniposide—lymphatic system cancer	7.33e-05	0.000715	CcSEcCtD
Busulfan—Pruritus—Fludarabine—lymphatic system cancer	7.27e-05	0.00071	CcSEcCtD
Busulfan—Back pain—Mitoxantrone—lymphatic system cancer	7.25e-05	0.000707	CcSEcCtD
Busulfan—Leukopenia—Carmustine—lymphatic system cancer	7.22e-05	0.000704	CcSEcCtD
Busulfan—Anorexia—Bleomycin—lymphatic system cancer	7.18e-05	0.000701	CcSEcCtD
Busulfan—Anaemia—Vincristine—lymphatic system cancer	7.11e-05	0.000694	CcSEcCtD
Busulfan—Agitation—Vincristine—lymphatic system cancer	7.07e-05	0.00069	CcSEcCtD
Busulfan—Hypotension—Bleomycin—lymphatic system cancer	7.04e-05	0.000687	CcSEcCtD
Busulfan—Diarrhoea—Fludarabine—lymphatic system cancer	7.03e-05	0.000686	CcSEcCtD
Busulfan—Convulsion—Carmustine—lymphatic system cancer	6.98e-05	0.000682	CcSEcCtD
Busulfan—Hypertension—Carmustine—lymphatic system cancer	6.96e-05	0.000679	CcSEcCtD
Busulfan—Nausea—Teniposide—lymphatic system cancer	6.95e-05	0.000678	CcSEcCtD
Busulfan—Anaemia—Mitoxantrone—lymphatic system cancer	6.93e-05	0.000676	CcSEcCtD
Busulfan—Leukopenia—Vincristine—lymphatic system cancer	6.89e-05	0.000672	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	6.87e-05	0.00067	CcSEcCtD
Busulfan—Chest pain—Carmustine—lymphatic system cancer	6.86e-05	0.00067	CcSEcCtD
Busulfan—Myalgia—Carmustine—lymphatic system cancer	6.86e-05	0.00067	CcSEcCtD
Busulfan—Anxiety—Carmustine—lymphatic system cancer	6.84e-05	0.000667	CcSEcCtD
Busulfan—Dyspnoea—Bleomycin—lymphatic system cancer	6.72e-05	0.000656	CcSEcCtD
Busulfan—Leukopenia—Mitoxantrone—lymphatic system cancer	6.71e-05	0.000655	CcSEcCtD
Busulfan—Convulsion—Vincristine—lymphatic system cancer	6.67e-05	0.000651	CcSEcCtD
Busulfan—Hypertension—Vincristine—lymphatic system cancer	6.64e-05	0.000648	CcSEcCtD
Busulfan—Confusional state—Carmustine—lymphatic system cancer	6.63e-05	0.000647	CcSEcCtD
Busulfan—Oedema—Carmustine—lymphatic system cancer	6.58e-05	0.000642	CcSEcCtD
Busulfan—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	6.57e-05	0.000641	CcSEcCtD
Busulfan—Decreased appetite—Bleomycin—lymphatic system cancer	6.55e-05	0.000639	CcSEcCtD
Busulfan—Myalgia—Vincristine—lymphatic system cancer	6.55e-05	0.000639	CcSEcCtD
Busulfan—Cough—Mitoxantrone—lymphatic system cancer	6.54e-05	0.000638	CcSEcCtD
Busulfan—Infection—Carmustine—lymphatic system cancer	6.54e-05	0.000638	CcSEcCtD
Busulfan—Vomiting—Fludarabine—lymphatic system cancer	6.54e-05	0.000638	CcSEcCtD
Busulfan—Convulsion—Mitoxantrone—lymphatic system cancer	6.49e-05	0.000634	CcSEcCtD
Busulfan—Rash—Fludarabine—lymphatic system cancer	6.48e-05	0.000632	CcSEcCtD
Busulfan—Dermatitis—Fludarabine—lymphatic system cancer	6.48e-05	0.000632	CcSEcCtD
Busulfan—Hypertension—Mitoxantrone—lymphatic system cancer	6.47e-05	0.000631	CcSEcCtD
Busulfan—Pain—Bleomycin—lymphatic system cancer	6.45e-05	0.000629	CcSEcCtD
Busulfan—Thrombocytopenia—Carmustine—lymphatic system cancer	6.44e-05	0.000629	CcSEcCtD
Busulfan—Headache—Fludarabine—lymphatic system cancer	6.44e-05	0.000628	CcSEcCtD
Busulfan—Tachycardia—Carmustine—lymphatic system cancer	6.42e-05	0.000627	CcSEcCtD
Busulfan—Chest pain—Mitoxantrone—lymphatic system cancer	6.38e-05	0.000623	CcSEcCtD
Busulfan—Myalgia—Mitoxantrone—lymphatic system cancer	6.38e-05	0.000623	CcSEcCtD
Busulfan—Arthralgia—Mitoxantrone—lymphatic system cancer	6.38e-05	0.000623	CcSEcCtD
Busulfan—Anxiety—Mitoxantrone—lymphatic system cancer	6.36e-05	0.00062	CcSEcCtD
Busulfan—Lethargy—Methotrexate—lymphatic system cancer	6.33e-05	0.000617	CcSEcCtD
Busulfan—Oedema—Vincristine—lymphatic system cancer	6.28e-05	0.000613	CcSEcCtD
Busulfan—Anorexia—Carmustine—lymphatic system cancer	6.27e-05	0.000612	CcSEcCtD
Busulfan—Infection—Vincristine—lymphatic system cancer	6.24e-05	0.000609	CcSEcCtD
Busulfan—Feeling abnormal—Bleomycin—lymphatic system cancer	6.21e-05	0.000606	CcSEcCtD
Busulfan—Confusional state—Mitoxantrone—lymphatic system cancer	6.17e-05	0.000602	CcSEcCtD
Busulfan—Nervous system disorder—Vincristine—lymphatic system cancer	6.16e-05	0.000601	CcSEcCtD
Busulfan—Thrombocytopenia—Vincristine—lymphatic system cancer	6.15e-05	0.0006	CcSEcCtD
Busulfan—Hypotension—Carmustine—lymphatic system cancer	6.15e-05	0.0006	CcSEcCtD
Busulfan—Oedema—Mitoxantrone—lymphatic system cancer	6.12e-05	0.000597	CcSEcCtD
Busulfan—Nausea—Fludarabine—lymphatic system cancer	6.11e-05	0.000596	CcSEcCtD
Busulfan—Infection—Mitoxantrone—lymphatic system cancer	6.08e-05	0.000593	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	5.99e-05	0.000585	CcSEcCtD
Busulfan—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	5.99e-05	0.000584	CcSEcCtD
Busulfan—Urticaria—Bleomycin—lymphatic system cancer	5.99e-05	0.000584	CcSEcCtD
Busulfan—Anorexia—Vincristine—lymphatic system cancer	5.99e-05	0.000584	CcSEcCtD
Busulfan—Tachycardia—Mitoxantrone—lymphatic system cancer	5.97e-05	0.000583	CcSEcCtD
Busulfan—Body temperature increased—Bleomycin—lymphatic system cancer	5.96e-05	0.000581	CcSEcCtD
Busulfan—Insomnia—Carmustine—lymphatic system cancer	5.95e-05	0.000581	CcSEcCtD
Busulfan—Skin disorder—Mitoxantrone—lymphatic system cancer	5.94e-05	0.00058	CcSEcCtD
Busulfan—Hypotension—Vincristine—lymphatic system cancer	5.87e-05	0.000573	CcSEcCtD
Busulfan—Dyspnoea—Carmustine—lymphatic system cancer	5.87e-05	0.000572	CcSEcCtD
Busulfan—Somnolence—Carmustine—lymphatic system cancer	5.85e-05	0.000571	CcSEcCtD
Busulfan—Anorexia—Mitoxantrone—lymphatic system cancer	5.83e-05	0.000569	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	5.72e-05	0.000558	CcSEcCtD
Busulfan—Decreased appetite—Carmustine—lymphatic system cancer	5.72e-05	0.000558	CcSEcCtD
Busulfan—Hypotension—Mitoxantrone—lymphatic system cancer	5.72e-05	0.000558	CcSEcCtD
Busulfan—Insomnia—Vincristine—lymphatic system cancer	5.68e-05	0.000554	CcSEcCtD
Busulfan—Gastrointestinal disorder—Carmustine—lymphatic system cancer	5.68e-05	0.000554	CcSEcCtD
Busulfan—Pain—Carmustine—lymphatic system cancer	5.63e-05	0.000549	CcSEcCtD
Busulfan—Constipation—Carmustine—lymphatic system cancer	5.63e-05	0.000549	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	5.57e-05	0.000544	CcSEcCtD
Busulfan—Hypersensitivity—Bleomycin—lymphatic system cancer	5.55e-05	0.000542	CcSEcCtD
Busulfan—Decreased appetite—Vincristine—lymphatic system cancer	5.46e-05	0.000533	CcSEcCtD
Busulfan—Dyspnoea—Mitoxantrone—lymphatic system cancer	5.45e-05	0.000532	CcSEcCtD
Busulfan—Somnolence—Mitoxantrone—lymphatic system cancer	5.44e-05	0.000531	CcSEcCtD
Busulfan—Gastrointestinal disorder—Vincristine—lymphatic system cancer	5.42e-05	0.000529	CcSEcCtD
Busulfan—Feeling abnormal—Carmustine—lymphatic system cancer	5.42e-05	0.000529	CcSEcCtD
Busulfan—Fatigue—Vincristine—lymphatic system cancer	5.41e-05	0.000528	CcSEcCtD
Busulfan—Asthenia—Bleomycin—lymphatic system cancer	5.41e-05	0.000528	CcSEcCtD
Busulfan—Dyspepsia—Mitoxantrone—lymphatic system cancer	5.38e-05	0.000525	CcSEcCtD
Busulfan—Gastrointestinal pain—Carmustine—lymphatic system cancer	5.38e-05	0.000525	CcSEcCtD
Busulfan—Pain—Vincristine—lymphatic system cancer	5.37e-05	0.000524	CcSEcCtD
Busulfan—Constipation—Vincristine—lymphatic system cancer	5.37e-05	0.000524	CcSEcCtD
Busulfan—Asthma—Methotrexate—lymphatic system cancer	5.36e-05	0.000523	CcSEcCtD
Busulfan—Pruritus—Bleomycin—lymphatic system cancer	5.33e-05	0.00052	CcSEcCtD
Busulfan—Decreased appetite—Mitoxantrone—lymphatic system cancer	5.32e-05	0.000519	CcSEcCtD
Busulfan—Fatigue—Mitoxantrone—lymphatic system cancer	5.27e-05	0.000515	CcSEcCtD
Busulfan—Pancreatitis—Methotrexate—lymphatic system cancer	5.25e-05	0.000513	CcSEcCtD
Busulfan—Pain—Mitoxantrone—lymphatic system cancer	5.23e-05	0.00051	CcSEcCtD
Busulfan—Constipation—Mitoxantrone—lymphatic system cancer	5.23e-05	0.00051	CcSEcCtD
Busulfan—Body temperature increased—Carmustine—lymphatic system cancer	5.2e-05	0.000508	CcSEcCtD
Busulfan—Abdominal pain—Carmustine—lymphatic system cancer	5.2e-05	0.000508	CcSEcCtD
Busulfan—Gastrointestinal pain—Vincristine—lymphatic system cancer	5.14e-05	0.000501	CcSEcCtD
Busulfan—Pancytopenia—Methotrexate—lymphatic system cancer	5.09e-05	0.000497	CcSEcCtD
Busulfan—Feeling abnormal—Mitoxantrone—lymphatic system cancer	5.04e-05	0.000492	CcSEcCtD
Busulfan—Neutropenia—Methotrexate—lymphatic system cancer	5.01e-05	0.000489	CcSEcCtD
Busulfan—Dysuria—Methotrexate—lymphatic system cancer	5.01e-05	0.000489	CcSEcCtD
Busulfan—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	5e-05	0.000488	CcSEcCtD
Busulfan—Abdominal pain—Vincristine—lymphatic system cancer	4.96e-05	0.000484	CcSEcCtD
Busulfan—Body temperature increased—Vincristine—lymphatic system cancer	4.96e-05	0.000484	CcSEcCtD
Busulfan—Erectile dysfunction—Methotrexate—lymphatic system cancer	4.94e-05	0.000482	CcSEcCtD
Busulfan—Urticaria—Mitoxantrone—lymphatic system cancer	4.86e-05	0.000474	CcSEcCtD
Busulfan—Hypersensitivity—Carmustine—lymphatic system cancer	4.85e-05	0.000473	CcSEcCtD
Busulfan—Abdominal pain—Mitoxantrone—lymphatic system cancer	4.84e-05	0.000472	CcSEcCtD
Busulfan—Body temperature increased—Mitoxantrone—lymphatic system cancer	4.84e-05	0.000472	CcSEcCtD
Busulfan—Pneumonia—Methotrexate—lymphatic system cancer	4.81e-05	0.000469	CcSEcCtD
Busulfan—Vomiting—Bleomycin—lymphatic system cancer	4.79e-05	0.000468	CcSEcCtD
Busulfan—Infestation NOS—Methotrexate—lymphatic system cancer	4.78e-05	0.000466	CcSEcCtD
Busulfan—Infestation—Methotrexate—lymphatic system cancer	4.78e-05	0.000466	CcSEcCtD
Busulfan—Depression—Methotrexate—lymphatic system cancer	4.76e-05	0.000465	CcSEcCtD
Busulfan—Rash—Bleomycin—lymphatic system cancer	4.75e-05	0.000464	CcSEcCtD
Busulfan—Dermatitis—Bleomycin—lymphatic system cancer	4.75e-05	0.000463	CcSEcCtD
Busulfan—Asthenia—Carmustine—lymphatic system cancer	4.72e-05	0.000461	CcSEcCtD
Busulfan—Renal failure—Methotrexate—lymphatic system cancer	4.7e-05	0.000458	CcSEcCtD
Busulfan—Stomatitis—Methotrexate—lymphatic system cancer	4.66e-05	0.000454	CcSEcCtD
Busulfan—Hypersensitivity—Vincristine—lymphatic system cancer	4.63e-05	0.000452	CcSEcCtD
Busulfan—Haematuria—Methotrexate—lymphatic system cancer	4.56e-05	0.000445	CcSEcCtD
Busulfan—Hepatobiliary disease—Methotrexate—lymphatic system cancer	4.52e-05	0.000441	CcSEcCtD
Busulfan—Epistaxis—Methotrexate—lymphatic system cancer	4.51e-05	0.00044	CcSEcCtD
Busulfan—Hypersensitivity—Mitoxantrone—lymphatic system cancer	4.51e-05	0.00044	CcSEcCtD
Busulfan—Asthenia—Vincristine—lymphatic system cancer	4.51e-05	0.00044	CcSEcCtD
Busulfan—Diarrhoea—Carmustine—lymphatic system cancer	4.5e-05	0.000439	CcSEcCtD
Busulfan—Nausea—Bleomycin—lymphatic system cancer	4.48e-05	0.000437	CcSEcCtD
Busulfan—Agranulocytosis—Methotrexate—lymphatic system cancer	4.46e-05	0.000435	CcSEcCtD
Busulfan—Asthenia—Mitoxantrone—lymphatic system cancer	4.39e-05	0.000428	CcSEcCtD
Busulfan—Dizziness—Carmustine—lymphatic system cancer	4.35e-05	0.000425	CcSEcCtD
Busulfan—Haemoglobin—Methotrexate—lymphatic system cancer	4.31e-05	0.000421	CcSEcCtD
Busulfan—Diarrhoea—Vincristine—lymphatic system cancer	4.3e-05	0.000419	CcSEcCtD
Busulfan—Haemorrhage—Methotrexate—lymphatic system cancer	4.29e-05	0.000419	CcSEcCtD
Busulfan—Pharyngitis—Methotrexate—lymphatic system cancer	4.26e-05	0.000415	CcSEcCtD
Busulfan—Urinary tract disorder—Methotrexate—lymphatic system cancer	4.24e-05	0.000413	CcSEcCtD
Busulfan—Urethral disorder—Methotrexate—lymphatic system cancer	4.2e-05	0.00041	CcSEcCtD
Busulfan—Diarrhoea—Mitoxantrone—lymphatic system cancer	4.18e-05	0.000408	CcSEcCtD
Busulfan—Vomiting—Carmustine—lymphatic system cancer	4.18e-05	0.000408	CcSEcCtD
Busulfan—Dizziness—Vincristine—lymphatic system cancer	4.15e-05	0.000405	CcSEcCtD
Busulfan—Rash—Carmustine—lymphatic system cancer	4.15e-05	0.000405	CcSEcCtD
Busulfan—Dermatitis—Carmustine—lymphatic system cancer	4.14e-05	0.000404	CcSEcCtD
Busulfan—Headache—Carmustine—lymphatic system cancer	4.12e-05	0.000402	CcSEcCtD
Busulfan—Erythema multiforme—Methotrexate—lymphatic system cancer	4.06e-05	0.000396	CcSEcCtD
Busulfan—Eye disorder—Methotrexate—lymphatic system cancer	4.01e-05	0.000391	CcSEcCtD
Busulfan—Vomiting—Vincristine—lymphatic system cancer	3.99e-05	0.00039	CcSEcCtD
Busulfan—Cardiac disorder—Methotrexate—lymphatic system cancer	3.98e-05	0.000388	CcSEcCtD
Busulfan—Rash—Vincristine—lymphatic system cancer	3.96e-05	0.000386	CcSEcCtD
Busulfan—Dermatitis—Vincristine—lymphatic system cancer	3.96e-05	0.000386	CcSEcCtD
Busulfan—Headache—Vincristine—lymphatic system cancer	3.93e-05	0.000384	CcSEcCtD
Busulfan—Nausea—Carmustine—lymphatic system cancer	3.91e-05	0.000381	CcSEcCtD
Busulfan—Angiopathy—Methotrexate—lymphatic system cancer	3.89e-05	0.00038	CcSEcCtD
Busulfan—Vomiting—Mitoxantrone—lymphatic system cancer	3.89e-05	0.000379	CcSEcCtD
Busulfan—Immune system disorder—Methotrexate—lymphatic system cancer	3.87e-05	0.000378	CcSEcCtD
Busulfan—Mediastinal disorder—Methotrexate—lymphatic system cancer	3.87e-05	0.000377	CcSEcCtD
Busulfan—Rash—Mitoxantrone—lymphatic system cancer	3.86e-05	0.000376	CcSEcCtD
Busulfan—Dermatitis—Mitoxantrone—lymphatic system cancer	3.85e-05	0.000376	CcSEcCtD
Busulfan—Chills—Methotrexate—lymphatic system cancer	3.85e-05	0.000376	CcSEcCtD
Busulfan—Headache—Mitoxantrone—lymphatic system cancer	3.83e-05	0.000374	CcSEcCtD
Busulfan—Alopecia—Methotrexate—lymphatic system cancer	3.79e-05	0.00037	CcSEcCtD
Busulfan—Mental disorder—Methotrexate—lymphatic system cancer	3.76e-05	0.000367	CcSEcCtD
Busulfan—Erythema—Methotrexate—lymphatic system cancer	3.73e-05	0.000364	CcSEcCtD
Busulfan—Malnutrition—Methotrexate—lymphatic system cancer	3.73e-05	0.000364	CcSEcCtD
Busulfan—Nausea—Vincristine—lymphatic system cancer	3.73e-05	0.000364	CcSEcCtD
Busulfan—Nausea—Mitoxantrone—lymphatic system cancer	3.63e-05	0.000355	CcSEcCtD
Busulfan—Back pain—Methotrexate—lymphatic system cancer	3.61e-05	0.000352	CcSEcCtD
Busulfan—Anaemia—Methotrexate—lymphatic system cancer	3.45e-05	0.000337	CcSEcCtD
Busulfan—Leukopenia—Methotrexate—lymphatic system cancer	3.34e-05	0.000326	CcSEcCtD
Busulfan—Cough—Methotrexate—lymphatic system cancer	3.26e-05	0.000318	CcSEcCtD
Busulfan—Convulsion—Methotrexate—lymphatic system cancer	3.24e-05	0.000316	CcSEcCtD
Busulfan—Arthralgia—Methotrexate—lymphatic system cancer	3.18e-05	0.00031	CcSEcCtD
Busulfan—Chest pain—Methotrexate—lymphatic system cancer	3.18e-05	0.00031	CcSEcCtD
Busulfan—Myalgia—Methotrexate—lymphatic system cancer	3.18e-05	0.00031	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	3.16e-05	0.000308	CcSEcCtD
Busulfan—Confusional state—Methotrexate—lymphatic system cancer	3.07e-05	0.0003	CcSEcCtD
Busulfan—Infection—Methotrexate—lymphatic system cancer	3.03e-05	0.000295	CcSEcCtD
Busulfan—Nervous system disorder—Methotrexate—lymphatic system cancer	2.99e-05	0.000292	CcSEcCtD
Busulfan—Thrombocytopenia—Methotrexate—lymphatic system cancer	2.98e-05	0.000291	CcSEcCtD
Busulfan—Skin disorder—Methotrexate—lymphatic system cancer	2.96e-05	0.000289	CcSEcCtD
Busulfan—Anorexia—Methotrexate—lymphatic system cancer	2.9e-05	0.000283	CcSEcCtD
Busulfan—Hypotension—Methotrexate—lymphatic system cancer	2.85e-05	0.000278	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	2.78e-05	0.000271	CcSEcCtD
Busulfan—Insomnia—Methotrexate—lymphatic system cancer	2.76e-05	0.000269	CcSEcCtD
Busulfan—Dyspnoea—Methotrexate—lymphatic system cancer	2.72e-05	0.000265	CcSEcCtD
Busulfan—Somnolence—Methotrexate—lymphatic system cancer	2.71e-05	0.000264	CcSEcCtD
Busulfan—Dyspepsia—Methotrexate—lymphatic system cancer	2.68e-05	0.000262	CcSEcCtD
Busulfan—Decreased appetite—Methotrexate—lymphatic system cancer	2.65e-05	0.000259	CcSEcCtD
Busulfan—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	2.63e-05	0.000257	CcSEcCtD
Busulfan—Fatigue—Methotrexate—lymphatic system cancer	2.63e-05	0.000256	CcSEcCtD
Busulfan—Pain—Methotrexate—lymphatic system cancer	2.61e-05	0.000254	CcSEcCtD
Busulfan—Feeling abnormal—Methotrexate—lymphatic system cancer	2.51e-05	0.000245	CcSEcCtD
Busulfan—Gastrointestinal pain—Methotrexate—lymphatic system cancer	2.49e-05	0.000243	CcSEcCtD
Busulfan—Urticaria—Methotrexate—lymphatic system cancer	2.42e-05	0.000236	CcSEcCtD
Busulfan—Body temperature increased—Methotrexate—lymphatic system cancer	2.41e-05	0.000235	CcSEcCtD
Busulfan—Abdominal pain—Methotrexate—lymphatic system cancer	2.41e-05	0.000235	CcSEcCtD
Busulfan—Hypersensitivity—Methotrexate—lymphatic system cancer	2.25e-05	0.000219	CcSEcCtD
Busulfan—Asthenia—Methotrexate—lymphatic system cancer	2.19e-05	0.000213	CcSEcCtD
Busulfan—Pruritus—Methotrexate—lymphatic system cancer	2.16e-05	0.00021	CcSEcCtD
Busulfan—Diarrhoea—Methotrexate—lymphatic system cancer	2.09e-05	0.000203	CcSEcCtD
Busulfan—Dizziness—Methotrexate—lymphatic system cancer	2.02e-05	0.000197	CcSEcCtD
Busulfan—Vomiting—Methotrexate—lymphatic system cancer	1.94e-05	0.000189	CcSEcCtD
Busulfan—Rash—Methotrexate—lymphatic system cancer	1.92e-05	0.000187	CcSEcCtD
Busulfan—Dermatitis—Methotrexate—lymphatic system cancer	1.92e-05	0.000187	CcSEcCtD
Busulfan—Headache—Methotrexate—lymphatic system cancer	1.91e-05	0.000186	CcSEcCtD
Busulfan—Nausea—Methotrexate—lymphatic system cancer	1.81e-05	0.000177	CcSEcCtD
